Yull Arriaga

2.3k total citations
54 papers, 798 citations indexed

About

Yull Arriaga is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yull Arriaga has authored 54 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yull Arriaga's work include Bladder and Urothelial Cancer Treatments (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Renal cell carcinoma treatment (5 papers). Yull Arriaga is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Renal cell carcinoma treatment (5 papers). Yull Arriaga collaborates with scholars based in United States, Germany and Spain. Yull Arriaga's co-authors include Yair Lotan, Arthur I. Sagalowsky, Ganesh V. Raj, Bruce J. Schlomer, Eugene P. Frenkel, Gretchen Purcell Jackson, Van C. Willis, Vitaly Margulis, Kenneth L. Kehl and Kevin D. Courtney and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Yull Arriaga

47 papers receiving 770 citations

Peers

Countries citing papers authored by Yull Arriaga

Since Specialization

Citations

This map shows the geographic impact of Yull Arriaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yull Arriaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yull Arriaga more than expected).

Fields of papers citing papers by Yull Arriaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yull Arriaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yull Arriaga. The network helps show where Yull Arriaga may publish in the future.

Co-authorship network of co-authors of Yull Arriaga

This figure shows the co-authorship network connecting the top 25 collaborators of Yull Arriaga. A scholar is included among the top collaborators of Yull Arriaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yull Arriaga. Yull Arriaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Variations in breast cancer surgical treatment and timing: determinants and disparities 2021 ·Breast Cancer Research and Treatment ·Irene Dankwa‐Mullan, (unknown), M. Christopher Roebuck, Joseph Tkacz, Van C. Willis, (unknown), Yull Arriaga	8
2	Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review 2021 ·JMIR Medical Informatics ·Van C. Willis, Kelly Jean Thomas Craig, Yalda Jabbarpour, (unknown), Yull Arriaga, (unknown), Kyu Rhee, Andrew Bazemore	57
3	A Targeted Review of Breast Cancer Studies of Concordance for an Internationally-Implemented Artificially Intelligent Clinical Decision-Support System 2020 ·Yull Arriaga, (unknown), (unknown), (unknown), Anita M. Preininger, Laura C Morgan, Kristina Lindsley, (unknown), Irene Dankwa‐Mullan, Kyu Rhee, Gretchen Purcell Jackson	0
4	A Narrative Review of Emerging Therapeutics for COVID-19 2020 ·SHILAP Revista de lepidopterología ·Van C. Willis, Yull Arriaga, Dilhan Weeraratne, (unknown), Gretchen Purcell Jackson	6
5	Early-onset colorectal cancer in younger patients: A population-based study. 2020 ·Journal of Clinical Oncology ·Hu Huang, (unknown), (unknown), Irene Dankwa‐Mullan, Gretchen Purcell Jackson, Yull Arriaga	0
6	Rapid review: Identification of digital health interventions in atherosclerotic-related cardiovascular disease populations to address racial, ethnic, and socioeconomic health disparities 2020 ·SHILAP Revista de lepidopterología ·Kelly Jean Thomas Craig, Nicole Fusco, Kristina Lindsley, Jane Snowdon, Van C. Willis, Yull Arriaga, Irene Dankwa‐Mullan	12
7	Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial 2019 ·Targeted Oncology ·Ali A. Mokdad, Hao Zhu, Muhammad S. Beg, Yull Arriaga, Jonathan E. Dowell, Amit G. Singal, Adam C. Yopp	17
8	Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients 2018 ·Clinical Cancer Research ·Masato Kobayashi, Jin-Sung Chung, Muhammad Shaalan Beg, Yull Arriaga, Udit Verma, Kevin D. Courtney, John C. Mansour, Barbara Haley, Saad A. Khan, Yutaka Horiuchi, Vijay Ramani, David Harker, Purva Gopal, (unknown), Ponciano D. Cruz, Kiyoshi Ariizumi	46
9	Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer 2018 ·Pancreas ·Jennifer H. Stern, Yull Arriaga, Arjun Gupta, Udit Verma, (unknown), Samira Syed, (unknown), John C. Mansour, (unknown), Philipp E. Scherer, Muhammad Shaalan Beg	3
10	Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis 2018 ·British Journal of Cancer ·David E. Gerber, Muhammad Shaalan Beg, Farjana Fattah, Arthur E. Frankel, (unknown), Yull Arriaga, Jonathan E. Dowell, (unknown), Richard D. Leff, Claudia Meek, William C. Putnam, Raja Reddy Kallem, (unknown), Ying Dong, (unknown), Venetia Sarode, Xin Luo, Yang Xie, Brian Schwartz, David A. Boothman	67
11	Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes 2018 ·European Urology Oncology ·Solomon L. Woldu, Joseph A. Moore, Bo Ci, Yuval Freifeld, Timothy N. Clinton, Ahmet Murat Aydın, Nirmish Singla, Laura-Maria Krabbe, Ryan Hutchinson, James F. Amatruda, Arthur I. Sagalowsky, Yair Lotan, Yull Arriaga, Vitaly Margulis, Yang Xie, Aditya Bagrodia	12
12	Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases 2018 ·Clinical Genitourinary Cancer ·I. Alex Bowman, (unknown), (unknown), Alana Christie, Zabi Wardak, Yull Arriaga, Kevin D. Courtney, Hans J. Hammers, Samuel Barnett, Bruce Mickey, Toral Patel, (unknown), Strahinja Stojadinović, Raquibul Hannan, Lucien Nedzi, Robert Timmerman, James Brugarolas	18
13	Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses 2017 ·Urology ·Solomon L. Woldu, Ahmet Murat Aydın, (unknown), Ryan Hutchinson, Nirmish Singla, Timothy N. Clinton, Laura-Maria Krabbe, Niccolò Passoni, Ganesh V. Raj, David S. Miller, James F. Amatruda, Arthur I. Sagalowsky, Yair Lotan, Yull Arriaga, Vitaly Margulis, Aditya Bagrodia	19
14	Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m) 2016 ·Annals of Oncology ·Rocio García‐Carbonero, Eric Van Cutsem, Fortunato Ciardiello, Marc Ychou, J.F. Seitz, (unknown), Yull Arriaga, Udit Verma, Axel Grothey, (unknown), J. Kalmus, Christian Kappeler, Alfredo Falcone, Alberto Zaniboni	5
15	PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC) 2016 ·Annals of Oncology ·Eric Van Cutsem, Fortunato Ciardiello, Marc Ychou, Jean‐François Seitz, Ralf‐Dieter Hofheinz, Yull Arriaga, Rocio García‐Carbonero, Axel Grothey, (unknown), J. Kalmus, Christian Kappeler, Alfredo Falcone, Alberto Zaniboni	2
16	A Case Report on the Effect of Everolimus in Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex 2014 ·Journal of Medical Cases ·(unknown), Yull Arriaga, (unknown)	1
17	Prospective Evaluation of a Molecular Marker Panel for Prediction of Recurrence and Cancer-specific Survival After Radical Cystectomy 2013 ·European Urology ·Yair Lotan, Aditya Bagrodia, Niccolò Passoni, (unknown), Payal Kapur, Yull Arriaga, Christian Bolenz, Vitaly Margulis, Ganesh V. Raj, Arthur I. Sagalowsky, Shahrokh F. Shariat	55
18	Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension 2012 ·Annals of Oncology ·(unknown), (unknown), Jonathan E. Dowell, Eileen M. Marley, (unknown), Yull Arriaga, Udit Verma	12
19	Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery 2008 ·British Journal of Urology ·Steven Lucas, Robert S. Svatek, (unknown), Yull Arriaga, Wareef Kabbani, Arthur I. Sagalowsky, Yair Lotan	66
20	Adverse Effects of Bevacizumab and Their Management in Solid Tumors 2006 ·PubMed ·Yull Arriaga, Carlos Becerra	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact